AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.43% to $145.65 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.30% to 4,017.77 and Dow Jones Industrial Average falling 0.77% to 33,717.09. This was the stock's third consecutive day of losses. AbbVie Inc. closed $30.26 below its 52-week high ($175.91), which the company reached on April 8th.
Despite its losses, the stock outperformed some of its competitors Monday, as Johnson & Johnson (JNJ) fell 3.70% to $162.00 and Pfizer Inc. (PFE) fell 0.55% to $43.55. Trading volume (4.6 M) remained 903,463 below its 50-day average volume of 5.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 30, 2023.
(END) Dow Jones Newswires
January 30, 2023 16:34 ET (21:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.